Teijin Pharma Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Teijin Pharma Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6499
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. Teijin Pharma business operations include research and development activities, manufacturing technology innovations and systems and product liability assessment systems. Its pharmaceutical pipeline products are intended for the treatment of tumor lysis syndrome, adenosine deaminase deficiency, optic neuritis, microscopic polyangiitis, neuroendocrine tumor, lumbar disc herniation, type 2 diabetes and others. The company’s pharmaceutical products comprises of inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, and others. Teijin Pharma’s home healthcare equipments include oxygen concentrators, sonic accelerated fracture healing system, and continuous positive airway pressure devices. The company has a presence in Europe, Asia and North America. Teijin Pharma is headquartered in Tokyo, Japan.

Teijin Pharma Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teijin Pharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Pharma Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Teijin Pharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Pharma Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Teijin Pharma Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Teijin Pharma Ltd, Medical Equipment, Deal Details 10
Asset Purchase 10
Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 10
Partnerships 11
Teijin Pharma Enters into Distribution Agreement with SRETT 11
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 12
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 13
Teijin Pharma Ltd – Key Competitors 14
Teijin Pharma Ltd – Key Employees 15
Teijin Pharma Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Recent Developments 18
Corporate Communications 18
Feb 06, 2017: Teijin Board Elects Akihisa Nabeshima as New President of Teijin Pharma 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Teijin Pharma Ltd, Medical Equipment, Key Facts 2
Teijin Pharma Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Teijin Pharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Pharma Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Teijin Pharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Pharma Ltd, Deals By Market, 2012 to YTD 2018 8
Teijin Pharma Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Teijin Pharma Acquires Rights of Neurostar TMS Device from Neuronetics 10
Teijin Pharma Enters into Distribution Agreement with SRETT 11
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 12
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 13
Teijin Pharma Ltd, Key Competitors 14
Teijin Pharma Ltd, Key Employees 15
Teijin Pharma Ltd, Other Locations 16
Teijin Pharma Ltd, Subsidiaries 16
Teijin Pharma Ltd, Joint Venture 17

List of Figures
Teijin Pharma Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Teijin Pharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Teijin Pharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Teijin Pharma Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Teijin Pharma Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Teijin Pharma Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Teijin Pharma Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Teijin Pharma Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Teijin Pharma Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Galenica Ltd:企業の戦略・SWOT・財務情報
    Galenica Ltd - Strategy, SWOT and Corporate Finance Report Summary Galenica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • New Zealand Oil & Gas Ltd (NZO):石油・ガス:M&Aディール及び事業提携情報
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Schlumberger Ltd (SLB):企業の財務・戦略的SWOT分析
    Schlumberger Ltd (SLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Concordia International Rx UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Concordia International Rx UK Ltd (Concordia International), formerly Amdipharm Mercury Company Ltd, a subsidiary of Concordia International Corp, is a manufacturer of pharmaceutical products and orphan drugs. The company’s products include acetazolamide, adenosine, adrenaline acid tartrate, …
  • RattanIndia Power Ltd (RTNPOWER):企業の財務・戦略的SWOT分析
    RattanIndia Power Ltd (RTNPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hurtigruten AS:企業の戦略・SWOT・財務情報
    Hurtigruten AS - Strategy, SWOT and Corporate Finance Report Summary Hurtigruten AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. It develops products using its proprietary peripheral arterial tonometry (PAT) …
  • Oaktree Capital Group Llc
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Physio-Control Inc:医療機器:M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Chunghwa Post Co., Ltd.:企業の戦略・SWOT・財務分析
    Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pvi Holdings
    Pvi Holdings - Strategy, SWOT and Corporate Finance Report Summary Pvi Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spineway SAS (ALSPW):企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Steward Health Care System LLC:企業の戦略的SWOT分析
    Steward Health Care System LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆